Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Nuvation Bio Inc. | Director | Class A Common Stock | 4,183,002 | $12.4 M | $2.97 | Jun 25, 2024 | By Decheng Anbio Limited |
Nuvation Bio Inc. | Director | Class A Common Stock | 2,453,131 | $7.29 M | $2.97 | Jun 25, 2024 | By Decheng Capital Global Healthcare Fund (Master), LP |
Nuvation Bio Inc. | Director | Class A Common Stock | 314,106 | $933 K | $2.97 | Jun 25, 2024 | By Decheng Capital China Life Sciences USD Fund III, L.P. |
Cue Health Inc. | Director | Common Stock | 788,441 | $237 K | $0.30 | Sep 28, 2021 | Indirect |
ALPINE IMMUNE SCIENCES, INC. | Director, 10%+ Owner | Common Stock | 0 | $0 | $6.33 | May 18, 2024 | Indirect |
ALPINE IMMUNE SCIENCES, INC. | Director, 10%+ Owner | Stock Option (Right to buy) | 0 | May 20, 2024 | Direct | ||
ALPINE IMMUNE SCIENCES, INC. | Director, 10%+ Owner | Warrant (right to buy) | 0 | Jan 18, 2024 | Indirect | ||
Cue Health Inc. | Director | Series C-1 Preferred Stock | 0 | Sep 28, 2021 | Indirect |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
NUVB | Nuvation Bio Inc. | Jun 25, 2024 | 1 | 825,348 | 4 | Jun 26, 2024 | Director |
NUVB | Nuvation Bio Inc. | Jun 20, 2024 | 3 | 1,492,385 | 4 | Jun 25, 2024 | Director |
ALPN | ALPINE IMMUNE SCIENCES, INC. | May 18, 2024 | 8 | 0 | 4 | May 20, 2024 | Director, 10%+ Owner |
NUVB | Nuvation Bio Inc. | Apr 9, 2024 | 3 | 0 | 4 | Apr 11, 2024 | Director |
NUVB | Nuvation Bio Inc. | Apr 9, 2024 | 0 | 0 | 3 | Apr 11, 2024 | Director |
ALPN | ALPINE IMMUNE SCIENCES, INC. | Jan 18, 2024 | 2 | 15,729,263 | 4 | Jan 22, 2024 | Director, 10%+ Owner |
ALPN | ALPINE IMMUNE SCIENCES, INC. | Jan 2, 2024 | 1 | 0 | 4 | Jan 4, 2024 | Director, 10%+ Owner |
ALPN | ALPINE IMMUNE SCIENCES, INC. | Nov 9, 2023 | 1 | 4,687,500 | 4 | Nov 14, 2023 | Director, 10%+ Owner |
ALPN | ALPINE IMMUNE SCIENCES, INC. | Jan 3, 2023 | 1 | 0 | 4 | Jan 5, 2023 | Director, 10%+ Owner |
ALPN | ALPINE IMMUNE SCIENCES, INC. | Sep 23, 2022 | 2 | 14,700,000 | 4 | Sep 27, 2022 | Director, 10%+ Owner |
ALPN | ALPINE IMMUNE SCIENCES, INC. | Jan 3, 2022 | 1 | 0 | 4 | Jan 4, 2022 | Director, 10%+ Owner |
HLTH | Cue Health Inc. | Sep 28, 2021 | 3 | 10,092,045 | 4 | Sep 30, 2021 | Director |
HLTH | Cue Health Inc. | Sep 23, 2021 | 0 | 0 | 3 | Sep 23, 2021 | Director, 10%+ Owner |
ALPN | ALPINE IMMUNE SCIENCES, INC. | Sep 17, 2021 | 1 | 14,499,998 | 4 | Sep 21, 2021 | Director, 10%+ Owner |